ALPK3 Heterozygous Truncating Variants Cause Late-Onset Hypertrophic Cardiomyopathy With Frequent Apical Involvement and Apical Aneurysm

Affiliations

• ¹ Cardiovascular Genetics Center, University of California, San Francisco. (L.B., E.A.H., A.P., J.W., V.V., E.J.H.).
• ² Cardiology Division, Cardiovascular Research Institute, University of California, San Francisco. (L.B., E.A.H., A.P., J.W., V.V., E.J.H.).
• ³ UCSF Hypertrophic Cardiomyopathy Center of Excellence, Division of Cardiology, University of California, San Francisco. (M.R.A., T.A.).
• ⁴ Department of Medicine and Cardiovascular Research Institute, University of California, San Francisco. (A.P., V.V.).
• ⁵ University of California San Francisco Genetic Counseling Program (G.W.).
• ⁶ Frankel Cardiovascular Center, Department of Internal Medicine, University of Michigan, Ann Arbo (R.A.).
• ⁷ Heart and Vascular Center, University of Chicago Medicine, IL (R.C.).
• ⁸ Knight Cardiovascular Institute, Oregon Health and Science University, Portland (E.J.).
• ⁹ Cardiovascular Division, University of Minnesota, Minneapolis (S.K.).
• ¹⁰ Baylor Scott and White The Heart Hospital at Plano, TX (K.L.).
• ¹¹ Division of Genetics, Department of Pediatrics, Children's Hospital of the Kings Daughters, Norfolk, VA (L.S.).
• ¹² Cardiovascular Division, Brigham and Women's Hospital, Boston, MA (C.P.).
• ¹³ Division of Cardiology, Department of Pediatrics, University of Virginia School of Medicine, Charlottesville (M.T.).
• ¹⁴ Bluhm Cardiovascular Institute, Northwestern Medicine, Winfield, IL (R.V.D.).